Sign In
Buy MSFT
$416.67
-11.38 (-2.66%)
At Close: Jun 05, 2026
Bill Gates Has Nearly 30% of His $35 Billion Portfolio in 1 Stock and It's Not Microsoft
08:18am, Wednesday, 18'th Mar 2026
The Gates Foundation owns a stock portfolio worth about $35 billion. The top holding isn't Microsoft, but Berkshire Hathaway.
2 Stocks I'm Buying for the Future of AI Work
08:05am, Wednesday, 18'th Mar 2026
AI has already worked its way into the daily workflow of many. And while it's acted more as an augmenter or amplifier so far, there's a shroud of uncertainty as to how the technology could reshape the
Bitcoin strategy fuels Connecting Excellence's recruitment growth
08:00am, Wednesday, 18'th Mar 2026
Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF) CEO Scott Ellam talked with Proactive about the company’s dual-engine strategy combining a scalable...
TTGI Insentra Expands U.S. Partner Services as Demand Surges for Microsoft AI and Security Expertise
08:00am, Wednesday, 18'th Mar 2026
Phoenix-based leadership outlines its vision for scaling partner growth and support across the U.S. under the TTGI platform Vancouver, Canada--(Newsfile Corp. - March 18, 2026) - Turnium Technology Gr
Microsoft Pushes Back On OpenAI Amazon Tie Up
07:43am, Wednesday, 18'th Mar 2026
Microsoft (MSFT) may be inching toward a showdown with Amazon (AMZN) and OpenAI, as a reported $50B deal starts to test the boundaries of its long-standing clou
Breakfast News: "Hungry Hippo" Boosts Rocket Lab
07:30am, Wednesday, 18'th Mar 2026
Rocket Lab reveals $816 million contract, Nvidia restarts China chip shipments, and more
Avity Investment Management Inc. Sells 3,144 Shares of Microsoft Corporation $MSFT
07:08am, Wednesday, 18'th Mar 2026
Avity Investment Management Inc. cut its stake in shares of Microsoft Corporation (NASDAQ: MSFT) by 2.4% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund o
Microsoft Considers Suing to Halt Amazon-OpenAI Cloud Deal
06:50am, Wednesday, 18'th Mar 2026
Microsoft is reportedly considering legal action over Amazon and OpenAI's new cloud deal.
Nextech3D.ai’s Krafty Labs unit achieves profitability in first month post-acquisition
06:31am, Wednesday, 18'th Mar 2026
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) announced that a recently acquired division Krafty Labs reached profitability in its first full month under...
Calamos Phineus Long/Short Fund Q4 2025 Contributors And Detractors
06:27am, Wednesday, 18'th Mar 2026
We continue to like United Airlines given structural improvement in industry dynamics and United's premium positioning in domestic air travel. We have periodically held a position on the view that Wel
VivoPower shares jump as it terminates $180M F-3 registration statement
06:17am, Wednesday, 18'th Mar 2026
Shares of VivoPower PLC (NASDAQ:VIVO, FRA:51J) surged 23.3% on Wednesday morning after the company announced it had terminated its $180 million Form F-3...
Sintana Energy partner secures 12-month extension on Namibia offshore license
06:11am, Wednesday, 18'th Mar 2026
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) announced that its joint venture partner, Pancontinental Energy Limited, has received...
Danica Pension Livsforsikringsaktieselskab Purchases Shares of 947,631 Microsoft Corporation $MSFT
05:29am, Wednesday, 18'th Mar 2026
Danica Pension Livsforsikringsaktieselskab acquired a new position in Microsoft Corporation (NASDAQ: MSFT) in the undefined quarter, according to its most recent Form 13F filing with the Securities an
Caitong International Asset Management Co. Ltd Decreases Stock Position in Microsoft Corporation $MSFT
05:29am, Wednesday, 18'th Mar 2026
Caitong International Asset Management Co. Ltd decreased its position in shares of Microsoft Corporation (NASDAQ: MSFT) by 60.7% during the undefined quarter, according to its most recent filing with
Protalix BioTherapeutics advances Fabry disease and gout programs during 2025
05:02am, Wednesday, 18'th Mar 2026
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined recent regulatory, clinical and commercial...
